W Y Weiser1, L M Pozzi, R G Titus
1Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Recombinant human migration inhibitory factor (MIF) enhances immune responses. This protein may serve as a valuable adjuvant for vaccine development, boosting T-cell proliferation and antibody production.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: